{"transactions":[{"id":3201810,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":150492,"kind":"person","name":"Discordia Robert Paul","position":1,"cik":"0001784644","reported_name":"Discordia Robert Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-03-18T15:21:52.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":2840,"price":3.54,"value":10053.6,"ownership":{"direct":true},"balance_after":35490,"source":{"system":"sec-edgar","filing":"0001209191-20-019931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919120019931/doc4.xml","form_type":"4"}},{"id":3219826,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":150492,"kind":"person","name":"Discordia Robert Paul","position":1,"cik":"0001784644","reported_name":"Discordia Robert Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option(right to buy)","published_at":"2020-03-09T21:24:23.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":226000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on March 6, 2021, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on April 6, 2021."}],"balance_after":226000,"derivative":{"exercise_price":4.53,"expiration_date":"2030-03-06","underlying":"Common Stock","underlying_shares":226000},"source":{"system":"sec-edgar","filing":"0001209191-20-017400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919120017400/doc4.xml","form_type":"4"}},{"id":3374003,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":150492,"kind":"person","name":"Discordia Robert Paul","position":1,"cik":"0001784644","reported_name":"Discordia Robert Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-11-12T14:57:47.000Z","date":"2019-11-11","kind":"purchase","acquired":true,"shares":2500,"price":4.6234,"value":11558.5,"ownership":{"direct":true},"balance_after":32650,"source":{"system":"sec-edgar","filing":"0001209191-19-055918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119055918/doc4.xml","form_type":"4"}},{"id":3440763,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":150492,"kind":"person","name":"Discordia Robert Paul","position":1,"cik":"0001784644","reported_name":"Discordia Robert Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-08-12T14:18:31.000Z","date":"2019-08-12","kind":"purchase","acquired":true,"shares":15000,"price":5.8596,"value":87894.0,"ownership":{"direct":true},"balance_after":30150,"source":{"system":"sec-edgar","filing":"0001209191-19-045442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119045442/doc4.xml","form_type":"4"}},{"id":3443266,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":150492,"kind":"person","name":"Discordia Robert Paul","position":1,"cik":"0001784644","reported_name":"Discordia Robert Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option(right to buy)","published_at":"2019-08-08T13:22:52.000Z","date":"2019-08-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on August 6, 2020, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on September 6, 2020."}],"balance_after":100000,"derivative":{"exercise_price":5.64,"expiration_date":"2029-08-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-045053","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119045053/doc4.xml","form_type":"4"}}]}